Lifecore Biomedical, Inc. (LFCR) stock
LFCRNasdaqPharmaceutical PreparationsFiscal year ends May 25
$6.39−0.03 (-0.39%)
Close on Nov 17, 2026Market cap $241.88MP/E –Yield –
Lifecore Biomedical revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Lifecore Biomedical's revenue for the twelve months ending May 25, 2025 was $128.87M, up 0.5% year over year. For fiscal 2025 it was $128.87M, up 0.5% from the year before. Over ten years it grew -13.3% a year on average. The highest annual figure on record is $557.56M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | May 25, 2025 | $128.87M | +0.5% |
| FY2024 | May 26, 2024 | $128.26M | +24.2% |
| FY2023 | May 28, 2023 | $103.27M | -7.2% |
| FY2022 | May 29, 2022 | $111.27M | +10.3% |
| FY2021 | May 30, 2021 | $100.87M | -37.0% |
| FY2020 | May 31, 2020 | $160.07M | -71.3% |
| FY2019 | May 26, 2019 | $557.56M | +6.4% |
| FY2018 | May 27, 2018 | $524.23M | +11.6% |
| FY2017 | May 28, 2017 | $469.78M | -1.5% |
| FY2016 | May 29, 2016 | $476.92M | -11.6% |
| FY2015 | May 31, 2015 | $539.26M | +13.1% |
| FY2014 | May 25, 2014 | $476.81M | +7.9% |
| FY2013 | May 26, 2013 | $441.71M | +39.1% |
| FY2012 | May 27, 2012 | $317.55M | +14.8% |
| FY2011 | May 29, 2011 | $276.73M | +16.2% |
| FY2010 | May 30, 2010 | $238.22M | – |
Quarterly revenue
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025CQ2 2025 | May 25, 2025 | $36.44M | -3.8% |
| Q3 FY2025CQ1 2025 | Feb 23, 2025 | $35.15M | -1.5% |
| Q2 FY2025CQ4 2024 | Nov 24, 2024 | $32.56M | +8.0% |
| Q1 FY2025CQ3 2024 | Aug 25, 2024 | $24.71M | +0.7% |
| Q4 FY2024CQ2 2024 | May 26, 2024 | $37.89M | +21.6% |
| Q3 FY2024CQ1 2024 | Feb 25, 2024 | $35.70M | +34.5% |
| Q2 FY2024CQ4 2023 | Nov 26, 2023 | $30.15M | +37.9% |
| Q1 FY2024CQ3 2023 | Aug 27, 2023 | $24.52M | +3.4% |
| Q4 FY2023CQ2 2023 | May 28, 2023 | $31.15M | +10.8% |
| Q3 FY2023CQ1 2023 | Feb 26, 2023 | $26.54M | -24.7% |
| Q2 FY2023CQ4 2022 | Nov 27, 2022 | $21.86M | -14.6% |
| Q1 FY2023CQ3 2022 | Aug 28, 2022 | $23.72M | +6.2% |
| Q4 FY2022CQ2 2022 | May 29, 2022 | $28.11M | -37.4% |
| Q3 FY2022CQ1 2022 | Feb 27, 2022 | $35.23M | +26.7% |
| Q2 FY2022CQ4 2021 | Nov 28, 2021 | $25.60M | +7.6% |
| Q1 FY2022CQ3 2021 | Aug 29, 2021 | $22.33M | -1.5% |
| Q4 FY2021CQ2 2021 | May 30, 2021 | $44.92M | -71.2% |
| Q3 FY2021CQ1 2021 | Feb 28, 2021 | $27.81M | -81.8% |
| Q2 FY2021CQ4 2020 | Nov 29, 2020 | $23.79M | -83.3% |
| Q1 FY2021CQ3 2020 | Aug 30, 2020 | $22.68M | -83.7% |
| Q4 FY2020CQ2 2020 | May 31, 2020 | $156.13M | +2.2% |
| Q3 FY2020CQ1 2020 | Feb 23, 2020 | $152.93M | -1.7% |
| Q2 FY2020CQ4 2019 | Nov 24, 2019 | $142.59M | +14.5% |
| Q1 FY2020CQ3 2019 | Aug 25, 2019 | $138.71M | +11.3% |
| Q4 FY2019CQ2 2019 | May 26, 2019 | $152.78M | +8.3% |
| Q3 FY2019CQ1 2019 | Feb 24, 2019 | $155.55M | +7.3% |
| Q2 FY2019CQ4 2018 | Nov 25, 2018 | $124.56M | +1.7% |
| Q1 FY2019CQ3 2018 | Aug 26, 2018 | $124.67M | +7.7% |
| Q4 FY2018CQ2 2018 | May 27, 2018 | $141.08M | +16.3% |
| Q3 FY2018CQ1 2018 | Feb 25, 2018 | $144.91M | +12.1% |
| Q2 FY2018CQ4 2017 | Nov 26, 2017 | $122.46M | +11.2% |
| Q1 FY2018CQ3 2017 | Aug 27, 2017 | $115.78M | +6.2% |
| Q4 FY2017CQ2 2017 | May 28, 2017 | $121.27M | -10.4% |
| Q3 FY2017CQ1 2017 | Feb 26, 2017 | $129.29M | -0.5% |
| Q2 FY2017CQ4 2016 | Nov 27, 2016 | $110.16M | – |
| Q1 FY2017CQ3 2016 | Aug 28, 2016 | $109.06M | – |
| Q4 FY2016CQ2 2016 | May 29, 2016 | $135.31M | – |
| Q3 FY2016CQ1 2016 | Feb 28, 2016 | $129.99M | – |
See a number that looks wrong?